PMC Links for Books (Select 4854626) - PMC

Result Filters

Links from Books

Items: 4

Select item 45308111.

An open-label expanded-access trial of bendamustine in patients with rituximab-refractory indolent non-Hodgkin lymphoma or previously untreated chronic lymphocytic leukemia: BEND-ACT

C.T. Kouroukis, M. Crump, D. MacDonald, J.F. Larouche, D.A. Stewart, J. Johnston, S. Sauvageau, E. Beausoleil, P. Sage, S.G. Dubois, A. Christofides, S. Di Clemente, L. Sehn

Curr Oncol. 2015 Aug; 22(4): 260–271. doi: 10.3747/co.22.2431

PMCID:: PMC4530811

Article PDF–634K

Select item 42609752.

Randomized trial of bendamustine-rituximab or R-CHOP/R-CVP in first-line treatment of indolent NHL or MCL: the BRIGHT study

Ian W. Flinn, Richard van der Jagt, Brad S. Kahl, Peter Wood, Tim E. Hawkins, David MacDonald, Mark Hertzberg, Yiu-Lam Kwan, David Simpson, Michael Craig, Kathryn Kolibaba, Samar Issa, Regina Clementi, Doreen M. Hallman, Mihaela Munteanu, Ling Chen, John M. Burke

Blood. 2014 May 8; 123(19): 2944–2952. Prepublished online 2014 Mar 3. doi: 10.1182/blood-2013-11-531327

PMCID:: PMC4260975

Article

Select item 41641053.

Severe Liver Damage and Nonallergic Bronchitis with Eosinophilia in a Patient with Follicular Lymphoma Treated with Bendamustine plus Rituximab

Tatsuro Jo, Kensuke Horio

Case Rep Oncol. 2014 May-Aug; 7(2): 497–502. Published online 2014 Jul 23. doi: 10.1159/000365566

PMCID:: PMC4164105

Article PDF–605K

Select item 29166804.

Bendamustine Is Effective Therapy in Patients With Rituximab-Refractory, Indolent B-cell Non-Hodgkin Lymphoma: Results From a Multicenter Study

Brad S. Kahl, Nancy L. Bartlett, John P. Leonard, Ling Chen, Kristen Ganjoo, Michael E. Williams, Myron S. Czuczman, K. Sue Robinson, Robin Joyce, Richard H. van der Jagt, Bruce D. Cheson

Cancer. Author manuscript; available in PMC 2010 Aug 5.

Published in final edited form as: Cancer. 2010 Jan 1; 116(1): 106–114. doi: 10.1002/cncr.24714